|
Jul 24
|
Triastek and BioNTech to develop 3D-printed RNA therapeutics
|
|
Jun 18
|
FDA puts partial clinical hold on BioNTech’s ADC trial after fatalities
|
|
Jun 18
|
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
|
|
Jun 17
|
Top Midday Stories: Nvidia Gets SCOTUS Review of Crypto Sales Lawsuit; Apple Supplier Develops Material for Solid-State Batteries; OpenAI Reportedly Launches Medical AI Tool; Walt Disney's 'Inside Out 2' Sets Biggest Opening of 2024; IQVentures to Acqu...
|
|
Jun 17
|
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
|
|
May 11
|
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
|
|
May 8
|
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
May 7
|
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
|
|
May 7
|
BioNTech reports net loss of €315.1m in Q1 2024
|
|
May 7
|
Q1 2024 BioNTech SE Earnings Call
|
|
May 6
|
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
|
|
May 6
|
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
|
|
May 6
|
BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline
|
|
May 6
|
What's Going With BioNTech Stock On Monday?
|
|
May 6
|
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
|
|
May 6
|
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
|
|
May 6
|
BioNTech says 90% of 2024 revenues will accrue at end of year
|
|
May 6
|
BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
|
|
May 3
|
Stocks to watch next week: BP, Saudi Aramco, Uber, and interest rates
|
|
May 3
|
Why Earnings Season Could Be Great for BioNTech (BNTX)
|